Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Home Depot
HD
|
+$246M |
| 2 |
ExxonMobil
XOM
|
+$96.1M |
| 3 |
Apple
AAPL
|
+$62M |
| 4 |
Verizon
VZ
|
+$58.6M |
| 5 |
Boeing
BA
|
+$52.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$174M |
| 2 |
SE
Spectra Energy Corp Wi
SE
|
+$85.4M |
| 3 |
STJ
St Jude Medical
STJ
|
+$69M |
| 4 |
Caterpillar
CAT
|
+$63.8M |
| 5 |
LLTC
Linear Technology Corp
LLTC
|
+$63.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.76% |
| 2 | Financials | 14.54% |
| 3 | Healthcare | 12.7% |
| 4 | Industrials | 11.05% |
| 5 | Consumer Discretionary | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2476
Limoneira
LMNR
$249M
| $846K | ﹤0.01% |
40,449
+2,052
| +5% | +$38.1K |
|
2477
Wave Life Sciences
WVE
$1.2B
| $845K | ﹤0.01% |
30,707
+1,881
| +7% | +$52.5K |
|
2478
TG Therapeutics
TGTX
$7.52B
| $840K | ﹤0.01% |
72,050
-26,200
| -27% | -$188K |
|
|
INSY
2479
DELISTED
Insys Therapeutics, Inc.
INSY
| $836K | ﹤0.01% |
79,468
+4,275
| +6% | +$45.5K |
|
2480
Medpace
MEDP
$16.8B
| $834K | ﹤0.01% |
27,922
+1,368
| +5% | +$44.2K |
|
2481
iShares Russell 2000 ETF
IWM
$81.5B
| $833K | ﹤0.01% |
6,054
+1,547
| +34% | +$211K |
|
|
TRK
2482
DELISTED
Speedway Motorsports, Inc.
TRK
| $832K | ﹤0.01% |
44,140
+2,223
| +5% | +$46.1K |
|
2483
El Pollo Loco
LOCO
$463M
| $830K | ﹤0.01% |
69,381
+3,933
| +6% | +$48.2K |
|
2484
Option Care Health
OPCH
$3.67B
| $830K | ﹤0.01% |
122,019
+5,899
| +5% | +$39K |
|
2485
Bar Harbor Bankshares
BHB
$660M
| $826K | ﹤0.01% |
24,957
+12,852
| +106% | +$377K |
|
|
KE
2486
Kimball Electronics
KE
$605M
| $826K | ﹤0.01% |
48,725
| – | – |
|
|
NETI
2487
DELISTED
Eneti Inc.
NETI
| $825K | ﹤0.01% |
9,638
| – | – |
|
2488
Smart Sand
SND
$197M
| $822K | ﹤0.01% |
50,536
+9,468
| +23% | +$162K |
|
|
ATRS
2489
DELISTED
Antares Pharma, Inc.
ATRS
| $822K | ﹤0.01% |
289,093
+26,847
| +10% | +$64.6K |
|
2490
Frontline
FRO
$8.56B
| $821K | ﹤0.01% |
121,763
+20,900
| +21% | +$146K |
|
2491
RadNet
RDNT
$6.08B
| $813K | ﹤0.01% |
137,732
-172,800
| -56% | -$1.03M |
|
|
EVRI
2492
DELISTED
Everi Holdings
EVRI
| $808K | ﹤0.01% |
168,564
+14,364
| +9% | +$46.9K |
|
2493
Natera
NTRA
$45.9B
| $804K | ﹤0.01% |
90,624
+5,130
| +6% | +$48.8K |
|
2494
Vanguard Morningstar Total Stock Market ETF
VTI
$691B
| $804K | ﹤0.01% |
6,626
-1,843
| -22% | -$221K |
|
2495
Geospace Technologies
GEOS
$72.8M
| $802K | ﹤0.01% |
49,397
+2,736
| +6% | +$51.8K |
|
2496
Rush Enterprises Class B
RUSHB
$6.06B
| $800K | ﹤0.01% |
57,697
+3,463
| +6% | +$48.1K |
|
|
EMCI
2497
DELISTED
EMC INS Group Inc
EMCI
| $799K | ﹤0.01% |
28,470
+1,197
| +4% | +$34.4K |
|
|
ACGN
2498
DELISTED
Aceragen Inc
ACGN
| $798K | ﹤0.01% |
2,377
+1,151
| +94% | +$278K |
|
|
JAG
2499
DELISTED
Jagged Peak Energy Inc.
JAG
| $794K | ﹤0.01% |
+60,825
| New | +$817K |
|
|
PCBK
2500
DELISTED
Pacific Continental Corp
PCBK
| $794K | ﹤0.01% |
32,400
| – | – |
|
Similar funds
Charles Schwab's Q1 2017 Portfolio in Review
As of Q1 2017, Charles Schwab held 3,112 positions worth $99.9B, up 9.4% from $91.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Charles Schwab deployed $4.38B of net new capital in Q1 2017, opening 37 new positions and adding to 2,360 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 413,073 shares worth $22.5M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Chevron, an estimated $174M trimmed.
- Charles Schwab's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 413,073 shares worth $22.5M.
- Charles Schwab added most to Home Depot in Q1 2017, an estimated $246M increase.
- Charles Schwab's biggest Q1 2017 reduction was Chevron, cutting an estimated $174M.
- Charles Schwab fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $85.4M.
- Charles Schwab's ten largest holdings make up 14% of its $99.9B portfolio in Q1 2017.
- Charles Schwab opened 37 new positions and closed 57 in Q1 2017.
- Charles Schwab's portfolio value rose 9.4% quarter-over-quarter to $99.9B.
Based on Charles Schwab's 13F filing for Q1 2017, filed 15 May 2017.